{
    "type": "VariantTherapeuticResponseProposition",
    "predicate": "sensitivity",
    "description": "Treatment of relapsed or refractory CD33-positive acute myeloid leukemia in adults and pediatric patients 2 years and older.",
    "geneContextQualifier": "CD33",
    "objectTherapeutic": "Gemtuzumab ozogamicin [Mylotarg]"
}